SurModics to Present at Canaccord Genuity Medical Technology and Diagnostics Forum
Webcast is Live on Thursday, November 19, at 11:40 a.m. (ET)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Nov. 11, 2015--
SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and
in vitro diagnostic technologies to the healthcare industry, announced
today that Gary Maharaj, president and chief executive officer, and Andy
LaFrence, vice president of finance and chief financial officer, will
make a presentation to the investment community at the Canaccord Genuity
Medical Technology and Diagnostics Forum in New York City on Thursday,
November 19, 2015, at 11:40 a.m. ET (10:40 a.m. CT).
A live audio webcast of the presentation will be available by going to
the investor relations portion of the Company’s website at www.surmodics.com
and clicking on the webcast icon. An audio replay will be available
beginning at noon CT on Thursday, November 19, and the webcast will be
archived for 90 days.
About SurModics, Inc.
SurModics partners with the world's
leading and emerging medical device, diagnostic and life sciences
companies to develop and commercialize innovative products designed to
improve lives by enabling the detection and treatment of disease. The
company’s core offerings include surface modification coating
technologies that impart lubricity, prohealing and biocompatibility
characteristics and components for in vitro diagnostic test kits
and microarrays. SurModics’ strategy is to build on the product and
technical leadership within these fields, and expand the core offerings
to generate opportunities for longer term sustained growth. SurModics is
headquartered in Eden Prairie, Minnesota. For more information about the
Company, visit www.surmodics.com.
The content of SurModics’ website is not part of this press release or
part of any filings that the Company makes with the SEC.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151111005225/en/
Source: SurModics, Inc.
Andy LaFrence, 952-500-7000